Preferred Label : pirtobrutinib;
CISMeF synonym : LOXO-305;
MeSH synonym : 5-amino-3-(4-(((5-fluoro-2-methoxybenzoyl)amino)methyl)phenyl)-1-((2S)-1,1,1-trifluoropropan-2-yl)pyrazole-4-carboxamide;
UNII : JNA39I7ZVB;
Origin ID : C000723100;
UMLS CUI : C5554559;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3639871/fr/jaypirca-pirtobrutinib-leucemie-lymphoide-chronique
2025
France
evaluation of the transparency committee
leukemia, lymphocytic, chronic, B-Cell
leukaemia
chronic lymphocytic leukemia
Jaypirca
pirtobrutinib
pirtobrutinib
leukemia, lymphoid
---
https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
pirtobrutinib
pirtobrutinib
pirtobrutinib
orphan drug production
Jaypirca
drug approval
europe
antineoplastic agents
antineoplastic agents
adult
lymphoma, mantle-cell
BTK Inhibitor
Agammaglobulinaemia Tyrosine Kinase
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
Refractory Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma
administration, oral
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
aged
drug evaluation, preclinical
---